Search

Your search keyword '"Anne Ricksten"' showing total 54 results

Search Constraints

Start Over You searched for: Author "Anne Ricksten" Remove constraint Author: "Anne Ricksten"
54 results on '"Anne Ricksten"'

Search Results

1. Donor Fractions of Cell-Free DNA Are Elevated During CLAD But Not During Infectious Complications After Lung Transplantation

2. Absolute Quantification of Donor-Derived Cell-Free DNA in Pediatric and Adult Patients After Heart Transplantation: A Prospective Study

3. Cell‐free DNA as a biomarker after lung transplantation: A proof‐of‐concept study

5. Cell-Free DNA after Heart Transplantation: New Aspects of the Story

6. A Standardized Protocol for Donor-Derived Cell-Free DNA Quantification in the Diagnosis of Allograft Injury

7. Cell-Free DNA in Different Clinical Scenarios after Heart Transplantation: Shedding Light or Obscuring the Picture?

8. BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia

9. Donor-derived Cell-free DNA Investigated by Digital PCR After Targeted Pre-Amplification: A Prospective Clinical Study of Heart-transplant Patients

10. EBNA1 expression in a lung transplant recipient with hypocomplementemic urticarial vasculitis syndrome

11. Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy

12. Glucose-Dependent Insulinotropic Polypeptide Is Expressed in Adult Hippocampus and Induces Progenitor Cell Proliferation

14. Serial Monitoring of BCR-ABL Transcripts in Chronic Myelogenous Leukemia (CML) Treated with Imatinib Mesylate

15. Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia

16. Tumor Necrosis Factor Gene Polymorphism Is Associated with Enhanced Systemic Inflammatory Response and Increased Cardiopulmonary Morbidity After Cardiac Surgery

17. The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia

18. Epstein–Barr virus U leader exon contains an internal ribosome entry site

19. Influence of the apolipoprotein E ε4 allele on human embryonic development

20. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos

21. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease

22. No association between the α2-macroglobulin (A2M) deletion and Alzheimer's disease, and no change in A2M mRNA, protein, or protein expression

23. SPECIFIC EXPRESSION OF EPSTEIN-BARR VIRUS IN CUTANEOUS SQUAMOUS CELL CARCINOMAS FROM HEART TRANSPLANT RECIPIENTS1

24. Are acetowhite lesions of the cervix correlated to the presence of Epstein-Barr virus DNA?

25. Diagnosis of Epstein-Barr virus-induced central nervous system infections by DNA amplification from cerebrospinal fluid

26. Was the C282Y mutation an Irish Gaelic mutation that the Vikings helped disseminate? HLA haplotype observations of hemochromatosis from the west coast of Sweden

27. Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia

28. Cell specific internal translation efficiency of Epstein-Barr virus present in solid organ transplant patients

29. Congenital Toxoplasma gondii Infection Diagnosed by PCR Amplification of Peripheral Mononuclear Blood cells from a Child and Mother

30. Not all imatinib resistance in CML are BCR-ABL kinase domain mutations

31. Alternative EBNA1 expression in organ transplant patients

32. The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera

33. Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate

34. Comparison of methods for polycythemia rubra vera-1 mRNA quantification in whole-blood leukocytes and purified granulocytes

35. Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia

36. The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia

37. Cutaneous squamoproliferative lesions in kidney transplant recipients: an investigation of specific Epstein-Barr virus expression

38. Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease

39. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection

40. Demonstration of Epstein-Barr virus DNA and human papillomavirus DNA in acetowhite lesions of the penile skin and the oral mucosa

41. Detection of cytomegalovirus DNA in cerebrospinal fluid in immunocompetent patients as a sign of active infection

42. Prevalence of Epstein-Barr virus and human papillomavirus in cervical samples from women attending an STD-clinic

43. Demonstration of Epstein-Barr virus DNA in acetowhite lesions of the vulva

44. Cytomegalovirus encephalitis in four immunocompetent patients

45. Tumor necrosis factor gene polymorphisms are associated with coronary artery vasculopathy in heart transplant recipients

46. Detection of Cytomegalovirus DNA in Serum Correlates with Clinical Cytomegalovirus Retinitis in AIDS

47. EBNA1 expression in a lung transplant recipient with hypocomplementemic urticarial vasculitis syndrome.

48. Cell specific internal translation efficiency of Epstein–Barr virus present in solid organ transplant patients.

49. Stable transfection of a human lymphoma line by sub-genomic fragments of Epstein-Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins

50. BamHI E region of the Epstein-Barr virus genome encodes three transformation-associated nuclear proteins

Catalog

Books, media, physical & digital resources